Sunday, January 20, 2008
How does Acomplia work?
How does Acomplia work? In the following I’ll try to answer this question that probably is in everyone’s mind when following a diet with acomplia.
Acomplia works in a very unique way. It blocks receptors that would otherwise receive messages of hunger and transmit those messages to the brain. In other words, Acomplia is an appetite suppressant. Combined with a low calorie diet and adequate exercise, people who take Acomplia can lose weight safely.
Another benefit of Acomplia is that it appears to suppress cravings for addictive substances like nicotine. Research has shown that smokers who take drug Acomplia are more likely to quit smoking and to do so without the usual weight gain that is often associated with quitting. In addition, levels of certain risk factors for heart disease improved in subjects who were given Acomplia in clinical trials. In particular, HDL (good) cholesterol levels rose, and triglyceride levels decreased. Further, blood glucose was better regulated in subjects who took Acomplia, so it can help people with diabetes lose weight as well as improve blood levels of sugar and fat.
The generic name for Acomplia is Rimonabant. It is expected that Sanofi-Aventis will call the drug Zimulti in the United States if it is approved for sale there. At the moment, the FDA is carefully examining data about Rimonabant in order to determine its safety and effectiveness as a treatment for obesity.
Acomplia works in a very unique way. It blocks receptors that would otherwise receive messages of hunger and transmit those messages to the brain. In other words, Acomplia is an appetite suppressant. Combined with a low calorie diet and adequate exercise, people who take Acomplia can lose weight safely.
Another benefit of Acomplia is that it appears to suppress cravings for addictive substances like nicotine. Research has shown that smokers who take drug Acomplia are more likely to quit smoking and to do so without the usual weight gain that is often associated with quitting. In addition, levels of certain risk factors for heart disease improved in subjects who were given Acomplia in clinical trials. In particular, HDL (good) cholesterol levels rose, and triglyceride levels decreased. Further, blood glucose was better regulated in subjects who took Acomplia, so it can help people with diabetes lose weight as well as improve blood levels of sugar and fat.
The generic name for Acomplia is Rimonabant. It is expected that Sanofi-Aventis will call the drug Zimulti in the United States if it is approved for sale there. At the moment, the FDA is carefully examining data about Rimonabant in order to determine its safety and effectiveness as a treatment for obesity.
Labels: Acomplia, Weight Loss, Zimulti
Subscribe to Posts [Atom]
